---
layout: post
title: "甘李药业股东拟减持不超2%公司股份"
date: 2022-02-23 20:21:34 +0800
categories: shanghaizhengquanbao·zhongguozhengquanwang
tags: 上海证券报·中国证券网新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.603087&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 603087_0" data-code="K 603087|1|1" data-code2="K 603087|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></p><!-- EM_StockImg_End --><p>甘李药业公告，自本公告发布之日起满15个交易日后的6个月内，持股14.25%的股东明华创新拟通过集中竞价交易方式合计减持数量不超过11,230,800股，即不超过公司总股本的2%。</p><p class="em_media">（文章来源：上海证券报·中国证券网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202232286461838>

[返回上海证券报·中国证券网新闻](//finews.withounder.com/category/shanghaizhengquanbao·zhongguozhengquanwang.html)｜[返回首页](//finews.withounder.com/)